Strain Data Sheet



BRC No.RBRC02830
TypeTransgene CongenicCartagena
SpeciesMus musculus
Strain nameB6.B6C3-Tg(Th-SNCA*140m)01-1Yosh
Former Common nameSyn140m-01-1, B6.Cg-Tg(Th-SNCA*)01-1Yosh
H-2 Haplotype
ES Cell line
Background strainC57BL/6JJcl
Strain developmentDeveloped by Masaki Wakamatsu, Makoto Yoshimoto, Taisho Pharmaceutical Co., Ltd. in 2001. The transgene was injected into the pronuclei of B6C3F1 fertilized eggs. The mutant mice were backcrossed C57BL/6.
Strain descriptionTh-SCNA transgenic mice expressing human alpha synuclein under the control of tyrosine hydroxylase promoter. Syn130m line (RBRC02829) having a human alpha synuclein sequence with an Ala53Thr point mutation and a lacking of 10 amino acids at the C-terminus, Syn140m line (RBRC02830) having a human alpa synuclein sequence with an Ala 53Thr point mutation. Syn130m line (RBRC02829) is useful as a model of Parkinson Disease. Syn130m Tg mice exhibit decreased dopamine level and dopaminergic neuron number. Motor activity and exploratory behavior are reduced compared to controls. Tg homozygous mice are postnatal lethal. Syn140m line (RBRC02830) is available as a control of Syn130m line. Syn140m Tg mice show no obvious abnormality.
Colony maintenanceCarrier x Noncarrier [C57BL/6JJcl]
ReferencesJ. Neurosci. Res., 85, 1819-1825 (2007) 17465029
Neurobiol. Aging, 29, 574-585 (2008) 17174013

Health Report

Examination Date / Room / Rack


Gene info
Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
SNCAsynuclein, alpha (human)UNSNCAsynuclein, alpharat tyrosine hydroxylase (TH) promoter

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
HBB2rabbit beta-globin intronUNHBB2

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
SV40 polyA-additional signalUN


Donor DNAhuman mutated α-synuclein cDNA (A53T), Rat Tyrosine hydroxylase promoter, Rabbit β-globin intron, SV40 polyA-additional signal
Research applicationMouse Models for Human Disease
Specific Term and ConditionsIn publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Neurosci. Res., 85, 1819-1825 (2007).
DepositorTaisho Pharmaceutical Co.,Ltd. (Taisho Pharmaceutical Co., Ltd.)
Strain Statusan icon for Frozen embryosFrozen embryos
an icon for Frozen spermFrozen sperm
Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
Cryopreserved sperm (within 1 month)
Cryopreserved embryos (within 1 month)
Additional Info.Necessary documents for ordering:
  1. Order form (Japanese / English)
  2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
  3. Acceptance of responsibility for living modified organism (Japanese / English)

Genotyping protocol -PCR-

BRC mice in Publications

Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H.
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.
Sci Rep 9(1) 7567(2019) 31110191